QUICKLINKS AND VIEW OPITONS
Medical expenses in those with diabetes, dyslipidemia or hypertension 30-60% higher in obese people
Monday, August 25, 2008 11:34 am Email this article
Annual medical expenses of obese people with diabetes, dyslipidemia (elevated LDL cholesterol, elevated triglycerides or low HDL cholesterol), or hypertension are 30-60 percent higher than normal weight people with these conditions according to a paper from the University of Colorado in Denver, Colorado, USA. Diabetes
Diabetes: 33% greater medical expenses
Obese people with diabetes have annual medical expenses 33 percent higher than normal weight people with diabetes: $7,986 versus $6,006.
Note: These medical expenses are in excess of normal weight people without these conditions.
In other words, annual medical expenses were $7,986 more in obese people with diabetes, and $6,006 more in normal weight people with diabetes than in normal weight people without diabetes.
Dyslipidemia (elevated LDL cholesterol, elevated triglycerides or low HDL cholesterol)
Dyslipidemia: 60% greater medical expenses
Obese people with dyslipidemia (elevated LDL cholesterol, elevated triglycerides or low HDL cholesterol) have annual medical expenses 60 percent higher than normal weight people with dyslipidemia: $7,636 versus $4,760.
Hypertension: 58% greater medical expenses
Obese people with hypertension have annual medical expenses 58 percent higher than normal weight people with dyslipidemia: $6,197 versus $3,911.
The study analyzed data from the 2000 and 2002 Medical Expenditure Panel Survey (MEPS), a nationally representative survey of the US population.
Conclusion: Obesity increases medical expenses
‘“Obesity significantly exacerbates the deleterious effect of diabetes, dyslipidemia, and hypertension on medical expenditures and productivity loss in the United States,” the authors of the paper concluded.
Sullivan PW, Ghushchyan V, Ben-Joseph RH. The effect of obesity and cardiometabolic risk factors on expenditures and productivity in the united states. Obesity (Silver Spring). 2008 Jun 26, 16(8):published early on-line.
AUTHOR’S CONTACT INFORMATION
Patrick W. Sullivan
Department of Clinical Pharmacy
University of Colorado at Denver and
Health Sciences Center
Pharmaceutical Outcomes Research Program
Denver, Colorado, USA
Articles on the same subject can be found here:
Please feel free to share your comments about this article.
© Copyright 2003-2017 - Larry Hobbs - All Rights Reserved.